Cargando…
Endocannabinoid signalling in the blood of patients with schizophrenia
AIM: To test the hypothesis that schizophrenia might be associated with alterations of the endogenous cannabinoid system in human blood. RESULTS: Blood from 20 healthy volunteers and 12 patients with schizophrenia, 5 of which both before and after a successful antipsychotic treatment, was analysed f...
Autores principales: | De Marchi, Nicola, De Petrocellis, Luciano, Orlando, Pierangelo, Daniele, Fabiana, Fezza, Filomena, Di Marzo, Vincenzo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194767/ https://www.ncbi.nlm.nih.gov/pubmed/12969514 http://dx.doi.org/10.1186/1476-511X-2-5 |
Ejemplares similares
-
Endocannabinoids, Related Compounds and Their Metabolic Routes
por: Fezza, Filomena, et al.
Publicado: (2014) -
Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats
por: Le Bacquer, Olivier, et al.
Publicado: (2021) -
The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020) -
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
por: Izzo, Angelo A., et al.
Publicado: (2007) -
Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)